Nancy Lurker, Director at EyePoint Pharmaceuticals, Inc. (EYPT), sold 9,300 shares at $15.11 ($141K) on 2025-12-04, disclosed to the SEC on 2025-12-05.
Scheduled sale ($141k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EYPT | BUY | 2024-08-20 | $25K | — | Filing → |
| EYPT | SELL | 2024-01-25 | $1.7M | — | Filing → |
| EYPT | SELL | 2023-12-06 | $830K | — | Filing → |